Penalized regression elucidates aberration hotspots mediating subtype-specific transcriptional responses in breast cancer

Bioinformatics

Volumn 27, Issue 19, 2011, Pages 2679-2685

  Yuan, Yinyin ^a,b   Rueda, Oscar M ^a,b   Curtis, Christina ^a,b,c   Markowetz, Florian ^a,b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; BREAST TUMOR; COMPUTER PROGRAM; COPY NUMBER VARIATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; GENOMIC INSTABILITY; HUMAN; METABOLISM; PHENOTYPE;

BREAST NEOPLASMS; DNA COPY NUMBER VARIATIONS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENOMIC INSTABILITY; HUMANS; MODELS, GENETIC; PHENOTYPE; SOFTWARE; TRANSCRIPTION, GENETIC;

EID: 80053452025     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btr450     Document Type: Article

References (47)

1. Adjei,A.A. and Hidalgo,M. (2005) Intracellular signal transduction pathway proteins as targets for cancer therapy. J. Clin. Oncol., 23, 5386-5403.
2. Akavia,U.D. et al. (2010) An integrated approach to uncover drivers of cancer. Cell, 143, 1005-1017.
3. Alizadeh,A.A. et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 503-511.
4. Bild,A.H. et al. (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature, 439, 353-357.
5. Chen,Y. et al. (2008)Variations inDNAelucidate molecular networks that cause disease. Nature, 452, 429-435.
6. Cheung,V.G. and Spielman,R.S. (2009) Genetics of human gene expression: mapping DNA variants that influence gene expression. Nat. Rev. Genet., 10, 595-604.
7. Chin,K. et al. (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell, 10, 529-541.
8. Chin,S.F. et al. (2007) High-resolution array-cgh and expression profiling identifies a novel genomic subtype of er negative breast cancer. Genome Biol., 8, R215.
9. Daemen,A. et al. (2009) A kernel-based integration of genome-wide data for clinical decision support. Genome Med., 1, 39.
10. Edelman,E.J. et al. (2008) Modeling cancer progression via pathway dependencies. PLoS Comput. Biol., 4, e28.
11. Furge,K.A. et al. (2007) Identification of deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profiling. Oncogene, 26, 1346-1350.
12. Goeman,J.J. (2010) L1 penalized estimation in the cox proportional hazards model. Biometrical J., 52, 70-84.
13. Golub,T.R. et al. (1999). Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science, 286, 531-537.
14. Greenman,C. et al. (2007). Patterns of somatic mutation in human cancer genomes. Nature, 446, 153-158.
15. Horlings,H.M. et al. (2010) Integration of DNAcopy number alterations and prognostic gene expression signatures in breast cancer patients. Clin. Cancer Res., 16, 651-663.
16. Huang,E. et al. (2003) Gene expression phenotypic models that predict the activity of oncogenic pathways. Nat. Genet., 34, 226-230.
17. Hummel,M. et al. (2006) A biologic definition of burkitt's lymphoma from transcriptional and genomic profiling. N. Engl. J. Med., 354, 2419-2430.
18. Karmakar,S. et al. (2009) Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity. Endocrinology, 150, 1588-1596.
19. Kostka,D. and Spang,R. (2004) Finding disease specific alterations in the co-expression of genes. Bioinformatics, 20 (Suppl. 1), i194-i199.
20. Liu,Y. and Ringnér,M. (2007) Revealing signaling pathway deregulation by using gene expression signatures and regulatory motif analysis. Genome Biol., 8, R77.
21. Mentzen,W.I. et al. (2009) Dissecting the dynamics of dysregulation of cellular processes in mouse mammary gland tumour. BMC Genomics, 10, 601.
22. Mo,W.J. et al. (2009) A stochastic model for identifying differential gene pair coexpression patterns in prostate cancer progression. BMC Genomics, 10, 340.
23. Pihur,V. et al. (2008) Reconstruction of genetic association networks from microarray data: a partial least squares approach. Bioinformatics, 24, 561-568.
24. Pollack,J.R. et al. (1999) Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat. Genet., 23, 41-46.
25. Pollack,J. et al. (2002) Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumours. Proc. Natl Acad. Sci. USA, 99, 12963-12968.
26. Reedijk,M. et al. (2005) High-level coexpression of JAG1 and NOTCH is observed in human breast cancer and is associated with poor overall survival. Cancer Res., 65, 8530-8537.
27. Rhodes,D.R. et al. (2004) Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl Acad. Sci. USA, 101, 9309-9314.
28. Rizzo,P. et al. (2008) Cross-talk between NOTCH and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res., 68, 5226-5235.
29. Rosenauer,A. et al. (1998) Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expression. Cancer Res., 58, 5110-5116.
30. Salari,K. et al. (2009) DR-Integrator: a new analytic tool for integrating DNA copy number and gene expression data. Bioinformatics, 26, 414-416.
31. Schäfer,J. and Strimmer,K. (2005b) A shrinkage approach to large-scale covariance matrix estimation and implications for functional genomics. Stat. Appl. Genet. Mol. Biol., 4, 32.
32. Schäfer,M. et al. (2009) Integrated analysis of copy number alterations and gene expression: a bivariate assessment of equally directed abnormalities. Bioinformatics, 25, 3228-3235.
33. Segal,E. et al. (2004)Amodule map showing conditional activity of expression modules in cancer. Nat. Genet., 36, 1090-1098.
34. Shi,W. et al. (2007) Detecting disease-causing genes by Lasso-patternsearch algorithm. BMC Proceed., 1 (Suppl. 1), S60.
35. Slavov,N. and Dawson,K. (2009) Correlation signature of the macroscopic states of the gene regulatory network in cancer. Proc. Natl Acad. Sci., 106, 4079.
36. Stylianou,S. et al. (2006) Aberrant activation of NOTCH signaling in human breast cancer. Cancer Res., 66, 1517-1525.
37. The Cancer Genome Atlas Research Network (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455, 1061-1068.
38. Tibshirani,R. (1994) Regression shrinkage and selection via the Lasso. J. R Stat. Soc., Series B, 58, 267-288.
39. Tibshirani,R. (1997) The Lasso method for variable selection in the Cox model. Stat. Med., 16, 385-395.
40. van de Wiel,M.A. and van Wieringen,W.N. (2007) CGHregions: Dimension reduction for array CGH data with minimal information loss. Cancer Informat., 3, 55-63.
41. Vogelstein,B. and Kinzler,K.W. (2004) Cancer genes and the pathways they control. Nat. Med., 10, 789-799.
42. Watters,J.W. and Roberts,C.J. (2006) Developing gene expression signatures of pathway deregulation in tumours. Mol. Cancer Ther., 5, 2444-2449.
43. West,M. et al. (2001) Predicting the clinical status of human breast cancer by using gene expression profiles. Proc. Natl Acad. Sci. USA, 98, 11462-11467.
44. Wu,T.T. et al. (2009) Genome-wide association analysis by Lasso penalized logistic regression. Bioinformatics, 25, 714-721.
45. Xu,M. et al. (2008) An integrative approach to characterize disease-specific pathways and their coordination: a case study in cancer. BMC Genomics, 9 (Suppl. 1), S12.
46. Zarubin,T. et al. (2005) Identification of eight genes that are potentially involved in tamoxifen sensitivity in breast cancer cells. Cell Res., 15, 439-446.
47. Zhang,B. et al. (2009) Differential dependency network analysis to identify conditionspecific topological changes in biological networks. Bioinformatics, 25, 526-532.